PROCEPT BioRobotics Corporation (PRCT) vs Vor Biopharma Inc. (VOR)

A side-by-side comparison of PROCEPT BioRobotics Corporation and Vor Biopharma Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — PRCT vs VOR

growth of $100 · dividends reinvested · last 5y
PRCT -57.5% (-15.7%/yr)VOR -94.1% (-43.2%/yr)PRCT compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $10020222023202420252026$42$6
PRCT VOR

PRCT vs VOR: by the numbers

  • •VOR is the larger company ($998M vs $994M market cap).
  • •Both run net losses; VOR's is the smaller (0.00% vs -32.54% net margin).

Metrics side by side

Valuation

MetricPRCTVOR
P/S ratio2.95N/A
P/B ratio2.92N/A

Profitability

MetricPRCTVOR
Gross margin63.74%0.00%
Operating margin-33.86%0.00%
Net margin-32.54%0.00%
ROE-32.27%N/A
ROIC-27.51%-32.24%

Growth (annualized)

MetricPRCTVOR
Revenue CAGR (5Y)74.27%N/A
Total return CAGR (5Y)-14.36%-42.54%

Frequently asked

How have PRCT and VOR total returns compared?
Over the past 5 years, PRCT delivered -14.36% and VOR delivered -42.54% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.